New shoulder implant shows promise in 87-Patient trial
NCT ID NCT04968405
First seen Apr 01, 2026 · Last updated May 11, 2026 · Updated 2 times
Summary
This study looked at how well a new shoulder replacement system (Catalyst CSR) works and if it is safe. It included 87 adults with shoulder arthritis, bone death, or rheumatoid arthritis. Researchers checked patients' pain, movement, and X-rays for up to 2 years after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS SHOULDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beaumont Hospital Royal Oak
Royal Oak, Michigan, 48073, United States
-
Kaiser Permanente Northwest Center for Health Research
Portland, Oregon, 97227, United States
-
Lifespan/University Orthopedics
Providence, Rhode Island, 02914, United States
Conditions
Explore the condition pages connected to this study.